Woolson Daniel 4
4 · ICU MEDICAL INC/DE · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Woolson Daniel
VP, GM-Infusion Capital
Transactions
- Tax Payment
Common Stock
2025-03-15$143.45/sh−1,294$185,624→ 14,194 total - Exercise/Conversion
Performance Shares
2025-03-15−2,923→ 2,924 totalExercise: $0.00Exp: 2026-03-15→ Common Stock (2,923 underlying) - Exercise/Conversion
Common Stock
2025-03-15+2,923→ 15,488 total
Footnotes (3)
- [F1]These Securities are Performance-based Restricted Stock Units (PRSU).
- [F2]There is neither a purchase price nor an exercise price for the PRSUs.
- [F3]These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant.